Tarenflurbil Terminated Phase 3 Trials for Alzheimer's Disease (AD) / Dementia Treatment

IndicationsStatusPurposePhase
TerminatedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00322036Global Efficacy Study of MPC-7869 to Treat Patients With Alzheimer's